CELEBRATING 24 YEARS IN BUSINESS OVER 300,000 CLIENTS REPRESENTED
Victoza gained FDA approval in 2010, for the treatment of Type 2 diabetes, yet only a short time later, adverse reports began coming in to the FDA. Victoza is manufactured by a Danish company, Novo Nordisk; the company was required to conduct a five-year study to determine the risks of pancreatitis, hypoglycemia, serious allergic reactions, pancreatic cancer and thyroid cancer among Victoza patients. Victoza was also approved with the understanding that it would be a second-line defense drug which means it would only be prescribed when other drug treatment was unsuccessful.
WARNING: Do not send any information in any email through this website if you consider the information confidential or privileged.
STARS ON YELP WITH OVER 400 REVIEWS*
*AS OF 2024
TOP 10 VERDICT IN TEXAS* 2022
*BY TOPVERDICT.COM
TOP 100 NATIONAL TRIAL LAWYER* 2013-2024
*BY THE NATIONAL TRIAL LAWYERS
AVVO CLIENT'S CHOICE AWARD* 2016, 2017, 2019-2024
*GIVEN BY AVVO
AMERICAN ASSOCIATION OF JUSTICE 2013-2024
*GRANTED BY THE AAJ